Can blood tests predict lung cancer return after immunotherapy?
NCT ID NCT05415358
First seen Feb 03, 2026 · Last updated Jun 09, 2026 · Updated 22 times
Summary
This study follows 23 people with advanced non-small cell lung cancer who have finished at least 20 months of immunotherapy. Researchers want to see if certain immune markers and DNA in the blood can predict whether the cancer will come back. The goal is to better understand who might need more treatment after stopping immunotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER, NONSMALL CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health Levine Cancer
Charlotte, North Carolina, 28204, United States
-
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.